Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0000899243-20-019573

Options or other derivatives

  • Chief Business Officer acquired 22,794 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Caffo Nathan Chief Business Officer 2020-07-16 Grant or award · Employee Stock Option (right to buy) +22,794 22,794 D: show line 1 in the form
Loading xslF345X03/doc4.xml…